Mifepristone 100 mg in abortion regimens

Mitchell D Creinin, Helen C. Pymar, Jill L. Schwartz

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

OBJECTIVE: To examine the clinical efficacy of mifepristone 100 mg followed 2 days later by misoprostol 400 μg orally or 800 μg vaginally in women at up to 49 days' gestation. METHODS: Eighty participants received mifepristone 100 mg and then were randomized to misoprostol, administered 48 hours later, at a dose of 400 μg orally (group 1) or 800 μg vaginally (group 2). Women returned for follow-up evaluations 24 ± 1 hour after using the misoprostol and then 2-3 weeks later. If abortion still had not occurred and the pregnancy was nonviable, the subject returned again after an additional 3 weeks. RESULTS: Twenty-four hours after receiving misoprostol, 34 (85%; 95% confidence interval [CI] 71%, 94%) of the 40 women in group 1 and 38 (95%; 95% CI 85%, 99%) of the 40 women in group 2 had complete abortions. Overall, complete abortion without surgical intervention occurred in 34 women in group 1 (85%; 95% CI 71%, 94%) and 40 women in group 2 (100%; 95% CI 91%, 100%; P = .03). Four women in group 1 required suction aspiration for continuing pregnancy at the second follow-up, compared with none in group 2 (P = .12). Side effects occurred with similar frequency in both treatment groups. CONCLUSION: Low-dose mifepristone (100 mg) combined with vaginal misoprostol 800 μg may be an effective alternative to regimens using 200 or 600 mg of mifepristone with misoprostol.

Original languageEnglish (US)
Pages (from-to)434-439
Number of pages6
JournalObstetrics and Gynecology
Volume98
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Mifepristone
Misoprostol
Confidence Intervals
Pregnancy
Suction

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Mifepristone 100 mg in abortion regimens. / Creinin, Mitchell D; Pymar, Helen C.; Schwartz, Jill L.

In: Obstetrics and Gynecology, Vol. 98, No. 3, 2001, p. 434-439.

Research output: Contribution to journalArticle

Creinin, Mitchell D ; Pymar, Helen C. ; Schwartz, Jill L. / Mifepristone 100 mg in abortion regimens. In: Obstetrics and Gynecology. 2001 ; Vol. 98, No. 3. pp. 434-439.
@article{1be2fca9b2e4457c8ebea314bff78ff3,
title = "Mifepristone 100 mg in abortion regimens",
abstract = "OBJECTIVE: To examine the clinical efficacy of mifepristone 100 mg followed 2 days later by misoprostol 400 μg orally or 800 μg vaginally in women at up to 49 days' gestation. METHODS: Eighty participants received mifepristone 100 mg and then were randomized to misoprostol, administered 48 hours later, at a dose of 400 μg orally (group 1) or 800 μg vaginally (group 2). Women returned for follow-up evaluations 24 ± 1 hour after using the misoprostol and then 2-3 weeks later. If abortion still had not occurred and the pregnancy was nonviable, the subject returned again after an additional 3 weeks. RESULTS: Twenty-four hours after receiving misoprostol, 34 (85{\%}; 95{\%} confidence interval [CI] 71{\%}, 94{\%}) of the 40 women in group 1 and 38 (95{\%}; 95{\%} CI 85{\%}, 99{\%}) of the 40 women in group 2 had complete abortions. Overall, complete abortion without surgical intervention occurred in 34 women in group 1 (85{\%}; 95{\%} CI 71{\%}, 94{\%}) and 40 women in group 2 (100{\%}; 95{\%} CI 91{\%}, 100{\%}; P = .03). Four women in group 1 required suction aspiration for continuing pregnancy at the second follow-up, compared with none in group 2 (P = .12). Side effects occurred with similar frequency in both treatment groups. CONCLUSION: Low-dose mifepristone (100 mg) combined with vaginal misoprostol 800 μg may be an effective alternative to regimens using 200 or 600 mg of mifepristone with misoprostol.",
author = "Creinin, {Mitchell D} and Pymar, {Helen C.} and Schwartz, {Jill L.}",
year = "2001",
doi = "10.1016/S0029-7844(01)01462-4",
language = "English (US)",
volume = "98",
pages = "434--439",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Mifepristone 100 mg in abortion regimens

AU - Creinin, Mitchell D

AU - Pymar, Helen C.

AU - Schwartz, Jill L.

PY - 2001

Y1 - 2001

N2 - OBJECTIVE: To examine the clinical efficacy of mifepristone 100 mg followed 2 days later by misoprostol 400 μg orally or 800 μg vaginally in women at up to 49 days' gestation. METHODS: Eighty participants received mifepristone 100 mg and then were randomized to misoprostol, administered 48 hours later, at a dose of 400 μg orally (group 1) or 800 μg vaginally (group 2). Women returned for follow-up evaluations 24 ± 1 hour after using the misoprostol and then 2-3 weeks later. If abortion still had not occurred and the pregnancy was nonviable, the subject returned again after an additional 3 weeks. RESULTS: Twenty-four hours after receiving misoprostol, 34 (85%; 95% confidence interval [CI] 71%, 94%) of the 40 women in group 1 and 38 (95%; 95% CI 85%, 99%) of the 40 women in group 2 had complete abortions. Overall, complete abortion without surgical intervention occurred in 34 women in group 1 (85%; 95% CI 71%, 94%) and 40 women in group 2 (100%; 95% CI 91%, 100%; P = .03). Four women in group 1 required suction aspiration for continuing pregnancy at the second follow-up, compared with none in group 2 (P = .12). Side effects occurred with similar frequency in both treatment groups. CONCLUSION: Low-dose mifepristone (100 mg) combined with vaginal misoprostol 800 μg may be an effective alternative to regimens using 200 or 600 mg of mifepristone with misoprostol.

AB - OBJECTIVE: To examine the clinical efficacy of mifepristone 100 mg followed 2 days later by misoprostol 400 μg orally or 800 μg vaginally in women at up to 49 days' gestation. METHODS: Eighty participants received mifepristone 100 mg and then were randomized to misoprostol, administered 48 hours later, at a dose of 400 μg orally (group 1) or 800 μg vaginally (group 2). Women returned for follow-up evaluations 24 ± 1 hour after using the misoprostol and then 2-3 weeks later. If abortion still had not occurred and the pregnancy was nonviable, the subject returned again after an additional 3 weeks. RESULTS: Twenty-four hours after receiving misoprostol, 34 (85%; 95% confidence interval [CI] 71%, 94%) of the 40 women in group 1 and 38 (95%; 95% CI 85%, 99%) of the 40 women in group 2 had complete abortions. Overall, complete abortion without surgical intervention occurred in 34 women in group 1 (85%; 95% CI 71%, 94%) and 40 women in group 2 (100%; 95% CI 91%, 100%; P = .03). Four women in group 1 required suction aspiration for continuing pregnancy at the second follow-up, compared with none in group 2 (P = .12). Side effects occurred with similar frequency in both treatment groups. CONCLUSION: Low-dose mifepristone (100 mg) combined with vaginal misoprostol 800 μg may be an effective alternative to regimens using 200 or 600 mg of mifepristone with misoprostol.

UR - http://www.scopus.com/inward/record.url?scp=0034830723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034830723&partnerID=8YFLogxK

U2 - 10.1016/S0029-7844(01)01462-4

DO - 10.1016/S0029-7844(01)01462-4

M3 - Article

C2 - 11530125

AN - SCOPUS:0034830723

VL - 98

SP - 434

EP - 439

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -